Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Seres Therapeutics, Inc. | Director | Stock Option (right to buy) | 35K | Jun 22, 2023 | Direct | ||
Axcella Health Inc. | Director | Stock Option (Right to Buy) | 20K | May 20, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MCRB | Seres Therapeutics, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
MCRB | Seres Therapeutics, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
MCRB | Seres Therapeutics, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |
AXLA | Axcella Health Inc. | May 20, 2021 | 1 | $0 | 4 | May 24, 2021 | Director |